Trials / Withdrawn
WithdrawnNCT01723579
Efficacy and Safety of Oral NOMAC-E2 in Indian Women (P07057/MK-8175A-017)
An Open-label, Multi-center Trial to Evaluate the Contraceptive Efficacy, Safety and Acceptability of a Monophasic Combined Oral Contraceptive (COC) Containing 2.5 mg Nomegestrol Acetate (NOMAC) and 1.5 mg Estradiol (E2) in Indian Women. Protocol MK-8175A-017-00
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This study will investigate the efficacy and safety of the monophasic combined oral contraceptive (COC) containing 2.5 mg NOMAC and 1.5 mg E2 in healthy fertile Indian women.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nomegestrol acetate (NOMAC) | Oral tablet with daily release of 2.5 mg |
| DRUG | Estradiol (E2) | Daily release of 1.5 mg |
Timeline
- Start date
- 2013-07-01
- Primary completion
- 2015-05-01
- Completion
- 2015-05-01
- First posted
- 2012-11-08
- Last updated
- 2022-02-16
Source: ClinicalTrials.gov record NCT01723579. Inclusion in this directory is not an endorsement.